Regarding the possible effect of IL-17 on this disease, it has been postulated that IL-17 could act as a profibrotic cytokine in IgG4-RD, as well as to promote inflammatory reactions in affected tissues [121], although further studies are needed in order to validate these findings. The gene discussed is IL17A; the disease is immunoglobulin G4-related sclerosing disease.